ANTIGENICS INC /DE/
ANTIGENICS INC /DE/ (AGEN) is a publicly traded company in the Unknown sector. Across all available filings, 28 corporate insiders have executed 578 transactions totaling $96.5M, demonstrating a bullish sentiment with $43.5M in net insider flow. The most recent transaction on Jan 9, 2026 involved a transaction of 3,780 shares valued at $14.8K.
AGEN Insider Activity Summary
Who Is Buying AGEN Stock?
No significant insider buying has been recorded for AGEN in the recent period.
Who Is Selling AGEN Stock?
No significant insider selling has been recorded for AGEN in the recent period.
Is ANTIGENICS INC /DE/ Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for AGEN is bullish with an Insider Alignment Score of 73/100 and a net flow of $43.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
AGEN Frequently Asked Questions
Understanding AGEN Insider Activity
Insider trading at ANTIGENICS INC /DE/ (AGEN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 28 insiders are actively trading AGEN stock, having executed 578 transactions in the past 90 days. The most active insider is Corp Incyte (Executive), who has made 6 transactions totaling $62.9M.
Related Tools
Track ANTIGENICS INC /DE/ Insider Activity
Get notified when executives and directors at AGEN file new Form 4 transactions